Jerusalem, (21, January 2021) - Nanosynex, a startup whose mission is to save lives by speeding up diagnostic processes, is working to bring a new inexpensive rapid testing kit that will successfully detect COVID-19 antigens in the Israeli market. The tests, which were developed by the startup’s strategic partner Biosynex, a leading French company in rapid diagnostic testing, are CE marked and currently pending approval of AMAR Israel’s drug and medical equipment regulator. Once approval is received, Nanosynex is ready to supply millions of units of the rapid testing kits to Israeli schools, nursing homes, airports, and workplaces, in order to enable people to perform quick Covid-19 testing and receive results in 15 minutes.

To further their mission, Nanosynex held a pilot demonstration for emergency medical personnel, team leaders, and first responders, in the headquarters of United Hatzalah in Jerusalem on Thursday morning. The demonstration was held in order to train members of United Hatzalah on how to properly administer the test in the hopes that they will be able to spread the information quickly to all their teams across the country once the tests get certification. Thus, enabling the national network of first responders to test themselves with quicker results, and thus lower the morbidity rate. As part of the demonstration, Nanosynex will be donating 200 kits to the organization to use in training their volunteers on its use.   

Join BJL on WhatsApp Status: Click here to Join BJL status for engagements, births, deals, levayos, events & more

Join BJL on WhatsApp Groups: Click here to Join an official BJL WhatsApp group for breaking news as it happens

Nanosynex a young R&D startup, whose main mission is to create a rapid diagnostic test platform to check the resistance of bacteria to antibiotics decided to join the fight against the pandemic by leveraging a strategic business partnership with Biosynex to bring the Covid-19 rapid testing kits to Israel.  

“Our partner developed two rapid tests that provide results that can be read by anyone in 15 minutes; one is serological and can detect antibodies for the virus in a person’s system, and the second detects the presence of the antigen or virus. The Antigen test kit has a sensitivity that is comparable, for contagious patients, to the regular polymerase chain reaction (PCR) test that is administered currently in Israel,” said Diane Abensur Bessin, the CEO and co-founder of Nanosynex. “The antigen rapid test got excellent traction in the EU where it received the CE Mark and is widely used for massive screening. Already, 15 million units have been sold in Europe. The test has also been placed in the reimbursement basket by the French government.”

Abensur Bessin spoke about why rapid testing is so urgently needed in Israel. “We are in the middle of the worst spike that we have seen from this pandemic. Our economy has been closed for almost a year and the infection is not slowing down despite a three-week lockdown. The widespread application of a rapid test will allow for mass screenings in a format that is less expensive, easy to use, without the use of laboratories, and will allow businesses and offices to reopen.”  

President and Founder of United Hatzalah Eli Beer said, “Our volunteers are on the front lines of the fight against the Covid-19 pandemic. In addition to treating more than 2,000 people per day for any medical emergency, our volunteers are transporting 200 Covid-19 patients per day. I want to make sure that when our volunteers rush out to treat someone or need to transport a patient, they are Covid free and that they come back from the incident Covid free. That is why I am so excited about this new rapid test. So that we can be a Covid free organization, so that when our volunteers return home, their families will be safe from exposure as well.”

Nanosynex co-founder and VP Marketing Michelle Heymann said, “We are happy to be partnering with United Hatzalah to spread the word about this new style of testing. We believe that every airport, school, nursing home and even supermarkets should use these screening methods to reduce morbidity and mortality rates and help our country to recover faster. We believe this form of testing could help improve the current crisis that is facing Israel and enable our health workers and first responders to provide better and safer care to the Israeli people.”